The National Center for Regenerative Medicine (NCRM) is a platform to facilitate translational research, clinical application, and commercialization of regenerative medicine, tissue engineering, and stem cell therapeutics across a consortium of institutions. NCRM is driven by four nationally ranked, medical research powerhouses, Case Western Reserve University, Cleveland Clinic, University Hospitals Case Medical Center and the Ohio State University. Through this network of researchers and clinicians, research discoveries are actively being translated into cell-based therapies for patient care.
NCRM is leading the way in Northeast Ohio in the following areas:
- Regenerative medicine and stem cell research
- Cellular manufacturing
- Clinical trials for cellular therapeutics
Global partnerships have been established with academic institutions and biotechnology companies to further expand research and discovery efforts.
NCRM Goals include:
Translational Research: To support stem cell and regenerative medicine research across various disciplines, institutions and commercial entities.
Education and Training: To develop cutting-edge education programs for researchers, clinicians, trainees and the general public.
Strategic Partnership: To build networks across academic, clinical, commercial and public sectors.
Commercialization: To translate innovative technologies and cell-therapies into business opportunities.